Profile for European Patent Office Patent: 3154561
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Denmark | CA 2024 00021 | ⤷ Start Trial |
| Netherlands | 301275 | ⤷ Start Trial |
| Lithuania | PA2024514 | ⤷ Start Trial |
| Luxembourg | LUC00343 | ⤷ Start Trial |
| Belgium | 2024C/518 | ⤷ Start Trial |
| Austria | 17/2024 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 3154561
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jun 12, 2035 | Ucb Inc | ZILBRYSQ | zilucoplan sodium |
| ⤷ Start Trial | Jun 12, 2035 | Ucb Inc | ZILBRYSQ | zilucoplan sodium |
| ⤷ Start Trial | Jun 12, 2035 | Ucb Inc | ZILBRYSQ | zilucoplan sodium |
| ⤷ Start Trial | Jun 12, 2035 | Ucb Inc | ZILBRYSQ | zilucoplan sodium |
| ⤷ Start Trial | Jun 12, 2035 | Ucb Inc | ZILBRYSQ | zilucoplan sodium |
| ⤷ Start Trial | Jun 12, 2035 | Ucb Inc | ZILBRYSQ | zilucoplan sodium |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
